BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2014
View Archived Issues
Philips to acquire Unisensor to enhance point-of-care diagnostic business
Read More
Celsion reports data from DIGNITY and HEAT studies
Read More
OJSC Pharmstandard and Millhouse acquire stakes in Biocad Holding
Read More
Otsuka Pharmaceutical signs collaboration agreement with Horizon CombinatoRx
Read More
Patient with congestive heart failure treated with combination stem cell treatment
Read More
Parnell in-licenses Cimtech compounds for bone and dermal regeneration
Read More
GlaxoSmithKline reviews pipeline progress of second quarter 2014
Read More
Phase III study of S-1 in hepatocellular carcinoma does not meet primary endpoint
Read More
Lpath reports interim data from phase IIa study of Asonep
Read More
Decoy Biosystems patents new bacterial agents for cancer
Read More
Scientists at Eli Lilly patent novel agents for insomnia
Read More
Novel SHIP-1 modulators disclosed by Aquinox Pharmaceuticals
Read More
Novel RNA-based transcriptional gene silencing strategy inhibits HIV-1 activation in vitro
Read More
Novo Nordisk receives positive CHMP opinion on Xultophy
Read More
Envarsus receives European approval for both kidney and liver transplant patients
Read More
Kinex Pharmaceuticals confirms FDA allowance of IND application for KX2-391 ointment
Read More
Discovery of new HIV-1 Gag mutations linked to protease inhibitor resistance
Read More
FDA clears IND for LOR-253 in patients with AML, MDS and other blood cancers
Read More
AcelRx Pharmaceuticals receives complete response letter from FDA for Zalviso
Read More
Simbrinza approved in the E.U. to treat glaucoma
Read More
Retrophin submits proposal to acquire Clinuvel Pharmaceuticals
Read More
Researchers in China present new proto-oncogene c-Abl inhibitors for cancer
Read More
Imbruvica granted full approval in U.S. for chronic lymphocytic leukemia
Read More
Arena Pharmaceuticals designs novel H3 receptor antagonists
Read More
Eli Lilly synthesizes novel autotaxin inhibitors for pain
Read More